What is Mobocertinib?

Mobocertinib/Mobocertinib(Mobocertinib) is a drug called a kinase inhibitor , for the treatment of locally advanced or metastatic non-small cell lung cancer in adults with epidermal growth factor receptor(EGFR)exon20 insertion mutations and whose disease has progressed during or after platinum-based chemotherapy. In 2021, the U.S. Food and Drug Administration(FDA) approved accelerated approval of mobotinib.

The recommended dose of mobosetinib is 160 mg taken orally once daily. Mobotinibcan be taken with or without food. Avoid eating grapefruit or drinking grapefruit juice while you are being treated with mobotinib. Grapefruit may increase the levels of mobotinib in your blood. While taking MobotinibPlease follow the recommendations of your medical staff. When taking, swallow the entire capsule and do not open, chew or dissolve the contents of the capsule. Do not change the dosage of the medicine or stop taking the medicine by yourself during the period of taking it. If the patient experiences certain side effects, the doctor will change the dose, temporarily stop or permanently stop the use of mobotinib treatment according to the patient's own situation. Ifthe patient is pregnant or planning to become pregnant, tell the doctor that mobotinib may harm an unborn baby. Patients should use an effective non-hormonal method of contraception during treatment and for 1month after the last dose of mobotinib. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to learn more about high-quality overseas drugs for you.